Patent Assertion and Litigation Funding Toolkit: Plaintiff Structures, Funding, and Defence Economics

By Casey Scott McKay · 2023-10-04

An assertion campaign is an economic exercise before it is a legal one, and the defendants who understand that settle for a fraction of what the ones who start with claim charts pay. This toolkit collects the whole framework. It covers plaintiff structures and the structure memorandum that reframes a matter in a day, the assignment chains and retained rights that support standing challenges, venue after TC Heartland, and the supplier tenders that shift part of the defence. It works joint defence groups and cost sharing, the review time bar and real party analysis, dispositive motion sequencing, discovery proportionality, funding disclosure, and damages comparables. It closes with settlement modelling against the plaintiff's actual structure, the fee record, and the collection theory that decides whether an award is worth pursuing.

IP and Technology > Patent Litigation | Toolkit | Published 4 October 2023 - Updated 15 November 2025 | Casey Scott McKay - marksy.us

Summary. An assertion campaign is an economic exercise before it is a legal one, and the defendants who understand that settle for a fraction of what the ones who start with claim charts pay. This toolkit collects the whole framework. It covers plaintiff structures and the structure memorandum that reframes a matter in a day, the assignment chains and retained rights that support standing challenges, venue after TC Heartland, and the supplier tenders that shift part of the defence. It works joint defence groups and cost sharing, the review time bar and real party analysis, dispositive motion sequencing, discovery proportionality, funding disclosure, and damages comparables. It closes with settlement modelling against the plaintiff's actual structure, the fee record, and the collection theory that decides whether an award is worth pursuing.

Keywords: assertion entity toolkit · plaintiff structure memorandum · assignment chain · retained rights · standing challenge · venue after TC Heartland · supplier indemnity tenders · joint defence groups · review time bar · real party in interest · litigation funding disclosure · eligibility motions · discovery proportionality · damages comparables · marking and notice · eBay injunction exposure · fee shifting after Octane · settlement modelling · collection theory · campaign defence capability

Start Here

Forty defendants receive substantially identical complaints on four patents from a plaintiff formed the previous year.

The defendants who spend day one on the plaintiff's structure and week two on forming a group settle at a fraction of what the ones who start with claim charts pay. That difference is not about the merits. It is about understanding what kind of matter this is.

An assertion campaign is an economic exercise before it is a legal one. The plaintiff's business model, its cost structure, its funding, and its exposure to counterclaims determine the settlement range far more reliably than the strength of the patents — and all of that is knowable in a day from public records.

Which is why the first deliverable is a structure memorandum, not a claim chart. Who is the plaintiff, when was it formed, what has it filed before, how did it acquire the patents, what rights did the prior owner retain, who else is connected to it, and what does it stand to lose if the case goes badly?

The answer determines everything downstream. A shell with no operations has no counterclaim exposure, no injunction interest under eBay v. MercExchange, and a cost structure that makes early settlement attractive to it. An operating company asserting against a competitor is a different matter entirely and should be defended differently.

This toolkit answers four questions. How is the plaintiff's structure established and what does it tell you? Which procedural moves change the cost curve, and in what order? How is discovery from and about the plaintiff framed so that it succeeds? And how is settlement modelled against the plaintiff's economics rather than against a trial outcome that will never arrive?

The framing that matters most. The defendant's objective is rarely a merits victory. It is to clear the matter at a cost proportionate to its actual exposure, and every step below is assessed against that.

The Structure Memorandum

Build it in the first week from public sources, and update it as discovery permits.

The plaintiff entity. Formation date and jurisdiction. Registered agent. Disclosed members or officers. The disclosure filed under Federal Rule of Civil Procedure 7.1, which is frequently empty and whose emptiness is itself informative.

Docket history. How many actions this plaintiff has filed, over what period, on which patents. How many by the same counsel on overlapping patents. Dispositions — settled, dismissed, adjudicated, tried. Median time to dismissal. Settlement amounts where public.

A plaintiff with eleven prior filings, nine settlements, and no trials is telling you its business model in a single line.

The patents. Numbers, issue dates, expiry dates, technology, and prior assertions of the same patents.

The assignment chain. Inventors to original assignee to any intermediate vehicle to the plaintiff, with reel and frame references from the recorded assignments under 35 U.S.C. § 261 and 37 C.F.R. § 3.11. Gaps identified. Unnamed potential co-inventors assessed against the Pannu v. Iolab standard, because an omitted unassigned inventor can license the patent to anyone.

Retained rights. Whether the prior owner retained a revenue share, a reversion, settlement approval rights, or a field limitation. This is where standing challenges come from, and Lone Star Silicon Innovations v. Nanya Technology supplies the framework for whether a transferee holds all substantial rights.

Related entities. Common members, addresses, counsel, or patents.

Funding indicators. Contingency counsel, a disclosed funder, or unexplained capacity to litigate.

The assessment. Plaintiff type — shell, acquisition vehicle, operating company, institution, or individual. Counterclaim exposure. Injunction exposure. An estimated clearing number with a basis. And a recommended sequence.

A day's work, and it reframes the matter.

The Front-Loaded Moves

These change the cost curve, and they must happen in the first weeks or not at all.

Supplier tenders. Where an accused feature comes from a supplier, tender the defence under the indemnity in the supply agreement. Do it immediately, because most indemnities carry notice conditions and late notice forfeits them. A tender accepted shifts part or all of the defence cost and frequently consolidates the campaign into one defence the supplier runs for all its customers.

Insurance notification. Some policies respond to intellectual property claims and most do not, but the notice conditions run from awareness rather than from a decision to claim.

Venue. TC Heartland v. Kraft Foods Group Brands restricts patent venue under 28 U.S.C. § 1400 to the district of incorporation or where the defendant has committed acts of infringement and has a regular and established place of business — with In re Cray defining what that requires. Venue objections are waived if not raised, and moving a case to the defendant's home district changes the schedule, the cost, and the settlement dynamics.

File the transfer motion under 28 U.S.C. § 1404 in the alternative, because convenience transfer reaches cases where venue is technically proper.

The defence group. In a campaign with many defendants, a joint defence group sharing invalidity work, prior art searching, claim construction, and expert costs reduces per-defendant spend by close to an order of magnitude. Form it in week two, with a written agreement addressing cost allocation, common interest privilege, information sharing limits, settlement independence, and what happens when a member settles.

Why speed matters here. The plaintiff's model depends on defendants deciding individually that settlement is cheaper than defence. A group changes that arithmetic, and it is hardest to form once early settlements have started.

The review time bar. 35 U.S.C. § 315 bars a petition filed more than a year after service of a complaint, and the same provision makes real party in interest identification a condition. Diary the deadline on day one, complete the real party analysis in time to file, and note that a group's members may each face different bars.

A stay pending review stops the cost clock, which is frequently worth more than the invalidity outcome.

Early dispositive motions. Eligibility under 35 U.S.C. § 101 and the Alice v. CLS Bank International framework can resolve a case before claim construction in the right technology. Indefiniteness under 35 U.S.C. § 112 and Nautilus v. Biosig Instruments is preserved through claim construction.

Standing

Where campaigns actually fail, and the reason the assignment chain work in the structure memorandum matters.

The question. Whether the plaintiff holds all substantial rights in the patents, which Lone Star Silicon Innovations v. Nanya Technology addresses by examining what the transferor retained rather than what the instrument calls itself.

What to look for in the chain. A retained revenue share. A reversion on defined events. Settlement approval rights held by the prior owner. A field limitation. Retained rights to practise. Retained enforcement rights. Any of these may mean the plaintiff cannot sue alone.

The remedy. Joinder of the prior owner, which changes the case materially — it introduces a party with operations, counterclaim exposure, and an interest in confidentiality that the shell did not have.

Gaps in the chain. Unrecorded assignments, assignments naming dissolved entities, and missing links between an original assignee and the plaintiff.

Inventorship. An unnamed co-inventor who has not assigned holds an undivided interest and may license the patent to anyone, including the defendant. Assess the Pannu v. Iolab standard against the technical record, and note that correction runs through 35 U.S.C. § 256.

Exhaustion. Where the plaintiff or a predecessor licensed a component supplier, an authorised sale may have exhausted the patent as to the accused products. The plaintiff's own licensing history is the source, and it is discoverable.

Practical sequencing. Raise standing early where the chain supports it, because it disposes of or reshapes the case before the expensive phases, and because a plaintiff forced to join its prior owner frequently finds settlement more attractive than it was.

Discovery, Framed to Succeed

The asymmetry. A defendant with operations has documents, source code, custodians, and witnesses. A shell plaintiff has a formation certificate, an assignment, and a contingency agreement. Discovery costs fall almost entirely on one side, and the plaintiff's model depends on that.

Proportionality is the answer. Federal Rule of Civil Procedure 26 requires discovery proportional to the needs of the case, and the argument is strongest when made early and quantitatively — custodian counts, date ranges, and estimated review costs measured against the plaintiff's own damages theory.

Negotiate custodians and date ranges before production, not after a dispute. Propose a phased approach tied to the accused products rather than to the company.

Source code. A protocol specifying review location, secure environment, printing limits, and expert access. This is where cost and risk concentrate, and an unfavourable protocol is difficult to unwind.

Discovery from the plaintiff, framed narrowly enough to be granted.

Prior licences on the asserted patents, which supply the damages comparables and may show exhaustion.
Prior settlements and their terms.
The assignment instruments and any side agreements, which support the standing analysis.
Communications with the prior owner about the assertion campaign.
Documents about the patents' valuation at acquisition.
Prior claim construction positions taken elsewhere on the same patents.
Prosecution files, where a candour question exists.

Funding and real party discovery. Frame it around a specific issue rather than as a general inquiry into who funds the plaintiff, because a general request is denied and a targeted one succeeds. The issues that support it: real party identification under 35 U.S.C. § 315, standing where a funder holds control rights, and conflicts where a funder is connected to a party.

Some courts require funding disclosure by standing order, and where one applies the information arrives without a motion. Check first.

Privilege in the group. A joint defence agreement establishes common interest, but the protection is not unlimited and members' shared analyses can be reached where the agreement is loose. Address what may be shared, in what form, and what happens on a member's settlement.

Opinion waiver. Where a defendant relies on an opinion of counsel to defeat wilfulness under Halo Electronics v. Pulse Electronics, the waiver reaches communications on the subject matter — a decision to be made deliberately rather than stumbled into. Commil USA v. Cisco Systems confirms that a good-faith belief in invalidity does not defeat induced infringement, which narrows what an opinion achieves.

Damages and Remedies

Comparables are the whole analysis. 35 U.S.C. § 284 provides for damages adequate to compensate, in no event less than a reasonable royalty — and a reasonable royalty is built from comparable licences.

Which is why the plaintiff's prior licences are the most valuable discovery in the case. A plaintiff that has settled eleven times at modest figures has established its own comparables, and they are frequently far below what it is demanding.

Apportionment. Where the patented feature is one of many in a product, damages must be apportioned to the value contributed by the invention rather than to the product as a whole.

Marking and notice. 35 U.S.C. § 287 conditions damages on marking or actual notice, and a plaintiff whose licensees sold unmarked products may have no pre-suit damages at all. This is a routine defence and it is routinely overlooked.

Injunctive relief. eBay v. MercExchange requires the traditional four factors, and a plaintiff that does not practise the invention rarely obtains one. A defendant should know this at the outset, because it removes the existential framing the complaint implies.

Enhanced damages. Halo Electronics v. Pulse Electronics makes enhancement available for egregious conduct without the rigid framework that preceded it, which raises the stakes on how a defendant responds to notice.

Fees. 35 U.S.C. § 285 permits fees in exceptional cases, and Octane Fitness v. ICON Health & Fitness lowered the standard to a case that stands out from others in the substantive strength of a party's position or the unreasonable manner in which it was litigated — with Highmark v. Allcare Health Management giving the district court deference.

Which makes the fee record a live project from day one. Deficiency letters documenting the plaintiff's failures. Theory shifts recorded as they occur. Contentions that changed without explanation. Positions abandoned late. Each entry is cheap at the time and cumulative.

Security for costs. Where the plaintiff is a shell, consider requesting security early, because it tests the funding and occasionally ends the case.

Settlement Modelling

Model against the plaintiff's economics, not against a trial outcome that will never arrive.

Build the defence cost curve by stage. Answer and initial motions. Venue and transfer. Claim construction. Fact discovery. Expert discovery. Summary judgment. Trial. Each stage has a cost, and the settlement value at any point is bounded by the cost of reaching the next one.

Then estimate the plaintiff's cost structure. Contingency counsel with no hourly exposure has a very different curve. A funded plaintiff has a burn rate and an investor expecting returns on a timetable. Both are more sensitive to delay than to merits.

The clearing number is the figure at which settlement is cheaper than continuing, adjusted for the probability and cost of each remaining stage and for the value of finality.

What moves it down. A venue transfer. A stay pending review. A pending eligibility motion. A standing challenge requiring joinder. A defence group sharing costs. A marking defence eliminating pre-suit damages. Comparables from the plaintiff's own prior licences.

What moves it up. A trial date approaching. A claim construction loss. An adverse review outcome. An acquisition or financing that makes certainty valuable.

Timing. The best moment is usually after a favourable procedural ruling and before the next expensive stage begins, and the worst is at the moment the plaintiff most wants to settle, which is when its own costs are about to rise.

Licence terms matter more than the number. Confirm the licence covers the whole family and continuations, affiliates and subsidiaries, suppliers and customers on the accused products, and successors. A licence covering only the named defendant on the named products leaves the campaign able to return through a supplier or after an acquisition.

Confirm the release is mutual and covers past conduct, that the covenant not to sue extends to related patents, and that the plaintiff represents it holds the rights it purports to grant — because a plaintiff without all substantial rights may not be able to release what the defendant is paying for.

Most-favoured-nation terms are worth asking for in a campaign, since later defendants frequently settle for less.

Confidentiality. The plaintiff will want it, and a defendant should consider whether disclosure of the amount helps other defendants and therefore the group.

Collection and the Other Side

Fee awards against a shell are frequently uncollectable, and the analysis belongs before the motion rather than after the award.

What to assess. The plaintiff's assets. Whether the patents themselves are the only asset and what they are worth. Whether a parent or member can be reached. Whether a funder's arrangement creates any exposure. Whether the prior owner retained rights that make it a real party.

A fee award nobody can collect still has value as a deterrent to the campaign and as a signal to other defendants, but it should not be pursued as though it were money.

For a client on the other side, running an assertion programme, the same framework read in reverse.

Document the pre-filing analysis. Claim charts per accused product, a validity assessment covering known art, standing and chain of title confirmed, and any candour question assessed — kept under privilege. Its absence is the first fact a fee motion or a sham counterclaim relies on.

Draft demand letters narrowly, identifying the patent, the claims, and the accused functionality, and drafting to the strictest applicable state bad-faith assertion statute as a matter of course. See state bad faith patent assertion statutes.

Confirm the assignment chain is clean and recorded before filing, because a standing defect discovered mid-case is expensive and occasionally fatal.

Consider what the structure signals. A plaintiff formed six months ago with an empty corporate disclosure invites exactly the analysis described above, and an operating company asserting its own patents does not.

Expect funding disclosure in an increasing number of forums, and structure the arrangement so disclosure is survivable.

Be consistent across defendants, because settling with early defendants at figures the later ones discover undermines the demand.

Campaign Defence Capability

For a company facing repeat assertions, build the capability once and every subsequent matter is cheaper.

The patent register. Every patent asserted against the company, with the chain, the retained rights, prior assertions, review outcomes, claim construction rulings entered elsewhere, and known licences.

The plaintiff register. Every asserting entity, with formation details, docket history, dispositions, related entities, counsel, funding indicators, and the clearing numbers observed.

Prior art library. Organised by technology area rather than by matter, so a search performed once serves later cases.

The supplier indemnity register. Which agreements contain indemnities, what the notice conditions are, and which suppliers have accepted tenders before. This determines whether a tender succeeds and it is a contract question rather than a litigation one.

Standard defence group agreement, pre-negotiated so formation takes days rather than weeks.

A decision framework. Which matters are defended, which are settled early, and who decides — because the most expensive outcome is an undecided matter accruing costs while the question is escalated.

Relationships. Counsel who have seen the same plaintiffs, and other frequent defendants who share information.

Metrics. Median clearing cost by plaintiff type. Time to structure memorandum. Tender acceptance rate. Group formation rate. Review institution rate. And cost per matter, trended — which is the number that shows whether the capability is working.

Litigation Funding

What it is. A third party finances the litigation in exchange for a share of the proceeds, non-recourse against the plaintiff.

Why it matters to a defendant. It changes the plaintiff's cost sensitivity, its settlement timing, and occasionally its identity for real-party purposes. A funded plaintiff can sustain a case a shell could not, and its investor has a timetable.

Disclosure. Some forums require it by standing order, some by local rule, and some not at all. Check first, because where an order applies the information arrives without a motion.

Where discovery into funding succeeds. Framed around a specific issue — real party identification under 35 U.S.C. § 315, standing where the funder holds control rights, or conflicts where a funder is connected to a party or the court. A general inquiry into who funds the plaintiff is denied.

Control is the operative question. A funder with rights over settlement decisions, litigation strategy, or counsel selection is closer to a real party than a passive investor, and the funding agreement's terms rather than its label determine that.

Privilege. Communications with a funder are frequently protected as work product where the funder is a party to a common interest or confidentiality arrangement, and the protection is not uniform across forums.

For a plaintiff's counsel. Structure the arrangement so the funder does not hold control rights that create real-party exposure, and assume the agreement may become discoverable.

Insurance products covering enforcement costs and adverse fee awards have emerged alongside funding, and they change the same calculus.

The contingency alternative. Counsel on contingency has no hourly exposure and a similar incentive structure, and a plaintiff with contingency counsel and no funder behaves much like a funded one for modelling purposes.

Review Proceedings

Why they dominate. An administrative review challenging validity runs on a statutory schedule, costs a fraction of district court litigation, and applies a different standard — and institution frequently produces a stay that stops the cost clock.

The time bar. 35 U.S.C. § 315 bars a petition filed more than a year after service of a complaint on the petitioner, its real party in interest, or its privy. Diary it on day one.

Real party identification is a condition. Getting it wrong risks the petition, and in a defence group each member's own bar and privity position must be assessed separately.

Estoppel. A petitioner that reaches a final written decision is estopped from raising grounds it raised or reasonably could have raised, which shapes what goes into the petition and what is preserved for the district court.

Sequencing against the district court case. A petition filed early enough to be instituted before claim construction maximises the stay prospect. Filing late reduces both the institution odds and the stay odds.

Discretionary denial. Institution is discretionary, and considerations including the parallel proceeding's schedule affect it. A case in a fast forum reduces the odds.

Group petitions. Cost-sharing across a defence group is efficient and creates joinder and estoppel complexities that the group agreement should address before filing.

What a stay is worth. Frequently more than the invalidity outcome, because it converts an escalating cost curve into a pause and shifts settlement leverage without any merits determination.

For a plaintiff. Expect petitions, and assess the portfolio's vulnerability before asserting rather than after institution.

A Worked Campaign

The facts. Twenty-two defendants, four patents, a plaintiff formed fourteen months earlier.

Week one. The structure memorandum took a day and reframed the matter. A shell, with patents acquired from a liquidated operating company through an intermediate vehicle that retained settlement approval rights, and eleven prior cases with nine settlements and no trials. Counterclaim exposure: none. Injunction exposure under eBay v. MercExchange: none realistic. Estimated clearing number: a small fraction of the opening demand.

Week one, also. Two supplier tenders sent under the indemnity provisions, both within the notice periods. Insurance notified. Venue analysed under TC Heartland v. Kraft Foods Group Brands and In re Cray.

Week two. Eighteen of the twenty-two defendants formed a group under a pre-negotiated agreement, cutting shared invalidity cost by close to an order of magnitude each. The review time bar was diaried and the real party analysis started.

Month two. A venue motion with a transfer motion under 28 U.S.C. § 1404 in the alternative moved the case to the defendants' home district, changing the schedule and the cost.

Month three. The retained settlement-approval right supported a standing challenge under Lone Star Silicon Innovations v. Nanya Technology that forced joinder of the prior owner — introducing a party with operations and an interest in confidentiality.

Month five. A review petition, filed inside the 35 U.S.C. § 315 window with the real party analysis complete, was instituted on two patents and produced a stay that stopped the cost clock at month ten.

Month twelve. Two patents held unpatentable. An eligibility motion under 35 U.S.C. § 101 pending on the remaining two.

Month eighteen. Settlement at a small fraction of the opening demand, on a licence covering the family, affiliates, suppliers, and successors.

The merits were reached only at the Board. Nothing above required a claim chart in the first month, and the defendants who started with one paid substantially more.

Common Errors

Starting with claim charts. They matter eventually and they are the wrong first week's work.

Missing the supplier tender window. Indemnities carry notice conditions and late notice forfeits them.

Waiving venue. The objection is lost if not raised, and it is the single cheapest change to the cost curve.

Forming the defence group late, after early settlements have started and the arithmetic has already shifted.

Missing the review time bar under 35 U.S.C. § 315, or filing with an incomplete real party analysis.

Framing funding discovery as a general inquiry, which is denied, rather than around a specific issue, which succeeds.

Overlooking the marking defence under 35 U.S.C. § 287, which can eliminate pre-suit damages entirely.

Not building the fee record contemporaneously, then trying to assemble one at the end.

Pursuing a fee award against a shell without assessing collection first.

Settling on a licence covering only the named defendant and the named products, so the campaign returns through a supplier or after an acquisition.

Treating an operating-company plaintiff like a shell, when its counterclaim exposure and injunction interest make it an entirely different matter.

Stumbling into opinion waiver rather than deciding it deliberately.

A Closing Note

An assertion campaign is an economic exercise, and the defendants who understand that in week one settle for a fraction of what the ones who start on the merits pay.

The structure memorandum costs a day and reframes the matter. The supplier tenders shift part of the defence and expire if not sent. The venue motion changes the schedule and is waived if not raised. The defence group changes the arithmetic the plaintiff's model depends on. The review petition stops the cost clock, and the standing challenge occasionally ends the case.

None of that is about whether the patents are good. It is about the cost curve, the plaintiff's economics, and the clearing number — and every one of those front-loaded moves has a deadline in the first weeks.

For a company facing repeat campaigns, build the capability once: the patent register, the plaintiff register, the prior art library organised by technology, the supplier indemnity register, and a pre-negotiated group agreement. The second campaign then costs a fraction of the first, which is the only durable answer to a business model built on making individual defence uneconomic.

The One-Page Position

Assertion matter — [defendant], [date]. Plaintiff: [entity], formed [date] in [jurisdiction]; type [shell / acquisition vehicle / operating company / institution / individual]; corporate disclosure under Federal Rule of Civil Procedure 7.1 [content / empty]. Docket history: [N] prior filings since [date]; [N] settled, [N] dismissed, [N] adjudicated, [N] tried; median time to dismissal [days]; public settlement range [figures]. Patents: [numbers], issued [dates], expiring [dates]; prior assertions [cases]; prior review outcomes [results]; prior claim construction rulings [forums]. Chain: [inventors] → [original assignee, reel/frame] → [vehicle, reel/frame] → [plaintiff, reel/frame]; gaps [list / none]; unnamed potential co-inventors [assessment]. Retained rights: [revenue share / reversion / settlement approval / field limitation / none]; standing assessment [sound / challengeable, basis]. Related entities: [list]. Funding indicators: [contingency counsel / disclosed funder / unexplained capacity / none apparent]; disclosure required in forum [yes/no]. Exposure: counterclaim [none / limited / substantial]; injunction under eBay v. MercExchange [none realistic / assess]; enhanced damages risk [assessment]. Tenders: [suppliers, dates, responses]; insurance notified [date]. Venue: incorporation [state]; regular and established place of business in district [yes/no]; motion filed [date]; transfer motion [date]. Group: [N] members; agreement [date]; cost formula [type]; shared spend [amount]; per-defendant saving [estimate]. Time bar: service [date]; 35 U.S.C. § 315 deadline [date]; real party analysis [date]; petition [filed / declined, reason]. Dispositive: eligibility motion [filed / assessed]; indefiniteness [preserved]; marking defence under 35 U.S.C. § 287 [assessed]. Discovery: custodians [N]; range [dates]; source code protocol [date]; plaintiff production [N documents]; prior licences obtained [N]; funding discovery [sought / obtained / denied]. Fee record: deficiency letters [dates]; theory shifts [N]; security requested [date]. Damages: comparables [N, range]; apportionment position [description]. Settlement: cost curve by stage [figures]; clearing estimate [range]; current demand [amount]; authority [tier]; licence scope required [family / affiliates / suppliers / successors]. Collection theory if fees awarded: [assessment]. Recommended actions: [list].

Metrics

Days from complaint to structure memorandum. Target under seven.
Supplier tenders sent within the notice period, as a percentage of matters with an indemnity available.
Tender acceptance rate.
Venue objections raised, as a percentage of matters where venue was defective.
Defence groups formed within three weeks, as a percentage of multi-defendant campaigns.
Review petitions filed inside the time bar with a complete real party analysis.
Institution rate, and stay rate on institution.
Median clearing cost by plaintiff type, trended.
Licence scope achieved — family, affiliates, suppliers, successors — as a percentage of settlements.
Repeat assertions from the same plaintiff after settlement. Target zero, and any non-zero result is a licence scope failure.
The one that matters. Cost per matter, trended across campaigns. It is the only number that shows whether the capability is working.

A note on the client conversation. A complaint reads as existential and rarely is. The first conversation should establish three things: that injunctive relief is unlikely where the plaintiff does not practise the invention, that the realistic range is a clearing number rather than a verdict, and that the decisions with the largest effect on cost all fall in the next three weeks. A client told that clearly makes those decisions; one told the case will be defended vigorously spends the three weeks waiting.

A note on scale. A single assertion against a small company and a forty-defendant campaign against an industry are the same analysis at different magnitudes. The structure memorandum, the tender, the venue objection, and the clearing number apply in both. What changes is whether a defence group is available and whether the review economics work — and for the smallest defendants, the answer is frequently to join a group formed by larger ones rather than to run any of it alone.

A Suggested Reading Path

For the framework:

For the venue and procedural layer:

For the competition and licensing dimension:

For the privilege and evidence layer:

Primary Authorities

| Authority | Proposition | |---|---| | 35 U.S.C. § 101 | Eligibility | | 35 U.S.C. § 102 | Novelty | | 35 U.S.C. § 103 | Obviousness | | 35 U.S.C. § 112 | Enablement; definiteness | | 35 U.S.C. § 256 | Correction of inventorship | | 35 U.S.C. § 261 | Assignment and recordation | | 35 U.S.C. § 271 | Infringement | | 35 U.S.C. § 284 | Damages | | 35 U.S.C. § 285 | Exceptional case fees | | 35 U.S.C. § 287 | Marking and notice | | 35 U.S.C. § 315 | Review time bar; real party in interest | | 28 U.S.C. § 1400 | Patent venue | | 28 U.S.C. § 1404 | Transfer for convenience | | 37 C.F.R. § 3.11 | Recording assignments | | Federal Rule of Civil Procedure 7.1 | Corporate disclosure | | Federal Rule of Civil Procedure 26 | Proportionality; work product | | TC Heartland v. Kraft Foods Group Brands | Patent venue restricted | | In re Cray | Regular and established place of business | | Lone Star Silicon Innovations v. Nanya Technology | All substantial rights and standing | | eBay v. MercExchange | Injunctive relief factors | | Octane Fitness v. ICON Health & Fitness | Exceptional case standard | | Highmark v. Allcare Health Management | Deference on fee awards | | Alice v. CLS Bank International | Abstract idea framework | | Nautilus v. Biosig Instruments | Definiteness | | Pannu v. Iolab | Joint inventorship | | Halo Electronics v. Pulse Electronics | Enhanced damages | | Commil USA v. Cisco Systems | Induced infringement and belief in invalidity |

Forms and Templates

The instrument that decides an assertion defence is not a pleading — it is the structure memorandum, and the Portfolio Inventory Template adapts to the register behind it. One row per asserted patent, with the number, issue and expiry dates, the technology, the recorded assignment chain with reel and frame references, the retained rights identified in each instrument, the prior assertions of the same patent and their dispositions, the review petitions filed against it and their outcomes, the claim construction rulings entered on it elsewhere, and the licences known to exist. That register is worth more than any single motion, and for a company facing repeat campaigns it is the asset that makes each subsequent matter cheaper.

The same template carries the campaign register: one row per plaintiff, with formation details, docket history, disposition statistics, related entities, counsel, funding indicators, and the clearing numbers observed. A company that has been asserted against three times has a database that a company facing its first assertion does not, and building it is the single highest-return investment in this practice.

The License Agreement Template is the settlement instrument, and its terms matter more than the number. Confirm the licence covers the whole patent family and continuations, affiliates and subsidiaries, suppliers and customers on the accused products, and successors — because a licence covering only the named defendant on the named products leaves the campaign able to return through a supplier or after an acquisition. Confirm the release is mutual and covers past conduct, that the covenant not to sue extends to related patents, and that the plaintiff represents it holds the rights to grant what it purports to grant. The Cease and Desist Template is the instrument on the other side, where a documented pre-filing analysis and a letter identifying the patent, the claims, and the accused functionality are what defeat a later bad-faith assertion claim.

Related Toolkits and Checklists

The Assertion and Funding Checklist runs the defence in the order the decisions arise, with the front-loaded steps that determine the cost curve first. The Patent Assertion Defense Toolkit covers the pre-litigation demand letter phase and the cost-effective response options before a complaint is filed. The IP and Antitrust Toolkit covers the fraudulent procurement and sham litigation theories that occasionally support a counterclaim, and the exhaustion and misuse defences that arise from the plaintiff's own licensing. The Privilege and Work Product Toolkit for IP Matters covers the common interest and opinion waiver questions that a joint defence group creates. The Semiconductor and Hardware IP Toolkit covers a sector that draws a disproportionate share of assertion campaigns, and the border remedy that makes them more dangerous there than elsewhere. And the IP Audit and Portfolio Governance Toolkit covers the supplier agreement and indemnity register that determines whether a tender succeeds.